Onco-Innovations Limited rejoices over the listing of its common stocks on the Canadian Stock Exchange (CBOE Canada)
Breaking News: Onco-Innovations Limited Busts onto Cboe Canada
Vancouver, BC - May 16, 2025 / IRW-Press / Onco-Innovations Limited (CSE: ONCO), now moves to shake up capital markets with its common shares transferring from the Canadian Securities Exchange (CSE) to Cboe Canada Inc. (Cboe Canada). This makes waves as Onco-Innovations' shares are set to start trading on Cboe Canada under the symbol ONCO on May 22, 2025 [1][2]. The delisting from the CSE will take place at the close on May 21, 2025 with no need for action from shareholders.
Why the Switch?Well, Cboe Canada, a Tier-1 exchange and part of the global Cboe Markets network, presents an internationally recognized platform for innovative companies seeking investor trust, liquidity, and visibility. With its robust platform, advanced market infrastructure, real-time data solutions, and the ETF Market Canada platform, showcasing over 1,200 Canadian ETFs, Onco-Innovations is poised to garner even more attention [1].
"We're stoked to shake things up a bit," shared Thomas OShaughnessy, CEO of Onco-Innovations. "This move aligns with our mission to create effective oncology solutions and broaden shareholder bases alongside forward-thinking, value-creating companies. We're all about pinpointing the perfect platform to bolster relationships with institutions and sort our capital strategy with our scientific ambitions" [1].
Onco-Innovations Explained:Specialize in cancer research and treatment, focusing on oncology, Onco-Innovations aims to prevent and cure cancer through pioneering research and trailblazing solutions. The company's worldwide exclusive license for a patented technology targeting solid tumors sets a new standard in cancer treatment [1].
"Cboe Canada is the new battleground for cutting-edge science and financial firepower," stated OShaughnessy. "We're here tomake a difference, and now we've got a killer lineup of investors and exchanges paving the way to victory" [1].
Onco-Innovations
[1] https://www.oncoinnovations.com/[2] Canadian Securities Exchange; Cboe Canada Inc.
LS Exchange ·
Cboe Canada Scoop:Cboe Canada, since launching in 2015, has supported issuers with an advanced market infrastructure and access to real-time data solutions. They're no stranger to innovation, opening the ETF Market Canada platform, an institutional resource for Canadian ETF research and analysis.
"We're psyched to welcome Onco-Innovations to our network," said Brian Pendergast, Cboe Canada's Chief Operating Officer. "We're committed to connecting ambitious innovators with responsible investors, creating a dynamic and accountable market space for the future. Onco-Innovations is fired up about taking on cancer, and we couldn't be more thrilled to help drive their ambition forward" [1].
Chart
Line chart with 18 data points.Chart für Onco-InnovationsThe chart has 1 X axis displaying Time. Data ranges from 2025-01-20 13:00:00 to 2025-05-16 14:00:00.The chart has 1 Y axis displaying values. Data ranges from 0.915 to 1.78.Lade...End of interactive chart.
For further information, contact:
Thomas OShaughnessyChief Executive OfficerTel: +1 888 261 [email protected]
- Onco-Innovations, a company specializing in cancer research and treatment, is joining Cboe Canada, a Tier-1 exchange known for its recognition in the global financial market, to enhance investor trust, liquidity, and visibility.
- By transitioning to Cboe Canada, Onco-Innovations is aligning with forward-thinking, value-creating companies, aiming to broaden shareholder bases and bolster relationships with institutions, thereby furthering its capital strategy with its scientific ambitions in oncology.
){kind=link}